Notices
Essential Drugs Division
KMSCL-E-tender for the Procurement of Deworming Medicines to the Animal Husbandry Department for the year 2024-25
Essential Drugs Division
KMSCL- E-tender for the Procurement of Veterinary Medicines for the year 2024-25- Technical Bid Evaluation - Defects noticed/status- Published- reg
Essential Drugs Division
KMSCL- Re-tender for the Procurement of Drugs/Supplies (Category III-VIII) for the year 2024-25- Final Bid Status- Corrigendum- Published-reg.
Essential Drugs Division
KMSCL – E-tender for the Procurement of Drugs & Growth Hormone for the treatment of Rare Disease for the year 2024-25 – Price Bid Evaluation – Final Bid status -Published – reg
Essential Drugs Division
KMSCL-E- tender for the Procurement of Drugs & Growth Hormone for the treatment of Rare Disease for the year 2024-25- Price Bid Evaluation- Final Bid status- Published- reg. Vide e-tender No- KMSCL/ED/RD-SAT/RC/2024/019 dated. 27.09.2024
Essential Drugs Division
Re-Tender for the supply of Insulin Cartridge and Pen for Mittayi Project– Technical Bid Evaluation–Defects noticed/status–Published
Essential Drugs Division
e-TENDER DOCUMENT FOR THE PROCUREMENT OF RECOMBINANT ANTI HAEMOPHILIC FACTOR VIII 500 IU
Essential Drugs Division
e-TENDER DOCUMENT FOR THE PROCUREMENT OF RECOMBINANT ANTI HAEMOPHILIC FACTOR VIII 1000 IU
Essential Drugs Division
e-TENDER DOCUMENT FOR THE PROCUREMENT OF RECOMBINANT ANTI HAEMOPHILIC FACTOR VIII 1500 IU
Essential Drugs Division
e-Tender for the Procurement of Drugs & Growth Hormone for the treatment of Rare Disease for the year 2024-25 – Price Bid Evaluation – Notice on Supplier wise rate quoted and Provisional Bid Ranking Status– Published
Essential Drugs Division
e-tender for the procurement Veterinary Medicines for Animal Husbandry department for the year 2024-25 - ANNEXURES WORD DOCUMENT
Essential Drugs Division
KMSCL- e- tender for the Procurement of Veterinary Medicines to the Animal Husbandry Department For the year 2024-25
Essential Drugs Division
Technical Bid Evaluation for E-tender for the Procurement of Insecticides for NVBDCP & Plan fund for 2023-24 & 2024-25
Essential Drugs Division
KMSCL- Re-tender for the Procurement of Anti- cancer Drugs for the year 2024-25- Price Bid Evaluation-Final Bid Status- Published- reg
Essential Drugs Division
KMSCL- Re-tender for the Procurement of Speciality Drugs for the year 2024-25- Price Bid Evaluation-Final Bid Status- Published- reg
Essential Drugs Division
KMSCL- Re-tender for the Procurement of Drugs for the year 2024-25- Price Bid Evaluation-Final Bid Status- Published- reg
Essential Drugs Division
Re-tender for the Procurement of Drugs for the year 2024-25- Price Bid Evaluation-Final Bid Status- Published- reg
Essential Drugs Division
Re-tender for the Procurement of Drugs for the year 2024-25– Price Bid Evaluation – Final Bid Status– Published
Essential Drugs Division
e-Tender for the Procurement of Drugs & Growth Hormone for the treatment of Rare Disease for the year 2024-25 – Technical Bid Evaluation – List of selected/rejected bidders/products for price bid evaluation–Published
Essential Drugs Division
Final Bid ranking status of Re-tender for the Procurement of Biolarvicide: Bacillus Thuringiensis var Israeliensis AS 5%(BTI) Serotype.H-14 for Surveillance and Control of Communicable Disease Scheme & NVBDCP for the year 2023-24
Essential Drugs Division
Re-tender for the Procurement of Drugs/Supplies(Category III-VIII) for the year 2024-25 – Price Bid Evaluation – Notice on Supplier wise rate quoted and Provisional Bid Ranking Status– Published
Essential Drugs Division
Re-tender for the procurement of IFA SYRUP for Anemia Mukth Bharat for the year 2023-2024
Essential Drugs Division
Re-tender for the procurement of IFA SYRUP for Anemia Mukth Bharat for the year 2023-2024
Essential Drugs Division
Re-tender for the procurement of IFA SYRUP for Anemia Mukth Bharat for the year 2023-2024
Essential Drugs Division
List of Selected bidders for Price Bid Opening of E-TENDER for the supply of Insulin Cartridge and Pen for Mittayi Project
Essential Drugs Division
KMSCL – Re-tender for the Procurement of Drugs/ Supplies for the year for the year 2024-25 – Technical Bid Evaluation – List of selected/rejected bidders/products for price bid evaluation–Published
Essential Drugs Division
Provisional Bid ranking status of Price bid evaluation of Re-tender for the Procurement of Biolarvicide: Bacillus Thuringiensis var Israeliensis (BTI) Serotype.H-14 for Surveillance and Control of Communicable Disease Scheme & NVBDCP for the year 2023-24
Essential Drugs Division
Provisional Bid ranking status of Price bid evaluation of Re-tender for the Procurement of Biolarvicide: Bacillus Thuringiensis var Israeliensis (BTI) Serotype.H-14 for Surveillance and Control of Communicable Disease Scheme & NVBDCP for the year 2023-24
Essential Drugs Division
"KMSCL –e-Tender for the procurement of drugs and Growth Hormone for the treatment of Rare Disease under NPRD scheme for the year 2024-25 – Amendment Notice – Published –reg
Essential Drugs Division
e-Tender for the procurement of drugs and Growth Hormone for the treatment of Rare Disease under NPRD scheme for the year 2024-25 – Time Extension Notice – Published –reg
Essential Drugs Division
Re-tender for the Procurement of Anti-Cancer Drugs for the year 2024-25 – Technical Bid Evaluation-List of selected/rejected bidders/products for price bid evaluation – Published
Essential Drugs Division
E-tender No. KMSCL/ED/RD-SAT/RC/2024/019 dated 13.09.2024 invited for the procurement of drugs for Rare Disease and Growth Hormone under NPRD Scheme
Essential Drugs Division
KMSCL- Re-tender for the Procurement of Drugs /Supplies for the year 2024- 25- Technical Bid Evaluation- Defects Noticed/Status- Publised -reg
Essential Drugs Division
KMSCL- E-Tender for the Procurement of Drugs for Anaemia Mukth Bharat for the year 2023-24-n Price bid evaluation - Final Bid ranking status - Published - reg
Essential Drugs Division
Re-tender for the procurement of Anti Cancer Drugs for the year 2024-25 - Technical Bid Evaluation - Defects noticed/status- Published
Essential Drugs Division
KMSCL Re-tender for the Procurement of Drugs for the year 2024-25–Price Bid Evaluation – Notice on Supplier wise rate quoted and Provisional Bid Ranking Status–Published–reg
Essential Drugs Division
KMSCL Re-tender for the Procurement of SpecialityDrugs for the year 2024-25–Price Bid Evaluation – Notice on Supplier wise rate quoted and Provisional Bid Ranking Status–Published–reg
Essential Drugs Division
Notice on Final Bid status against the e-tender for the Procurement of Drugs for De- Addiction Centres for the year 2024-25
Essential Drugs Division
E-TENDER DOCUMENT FOR THE PROCUREMENT OF INSECTICIDES For NVBDCP & PLAN SCHEME for the year 2023-24 & 2024-25
Essential Drugs Division
Provisional Bid ranking status of Price bid evaluation against e-tender for the Procurement of Drugs for Anaemia Mukth Bharat for the year 2023-24
Essential Drugs Division
List of selected/ rejected bidders/products for price bid evaluation against Re-tender for the Procurement of Biolarvicide: Bacillus Thuringiensis var Israeliensis (BTI) Serotype.H-14 for Surveillance and Control of Communicable Disease Scheme & NVBDCP for the year 2023-24
Essential Drugs Division
KMSCL -E-tender for the Procurement of Veterinary Medicines for the year 2023-24-Price Bid Evaluation- Final Bid status -Published-reg: vide tender no:- KMSCL/AHD-VET/RC/2024/004; Dated 08.04.2024
Essential Drugs Division
List of selected/ rejected bidders/products for price bid evaluation against E- Tender for the Procurement of Drugs for Anaemia Mukth Bharat for the year 2023-24 vide e-tender No-KMSCL/ED/IFA/RC/2024/009 dtd. 04.06.2024
Essential Drugs Division
E-TENDER for the supply of Insulin Cartridge and Pen for Mittayi Project -vide tender No- E-tender No.KMSCL/ED/ /MITTAYI/ RC/2024/010 DTD.11-06-2024.
Essential Drugs Division
Procurement of Drugs for De-Addiction Centres for the year 2024-25 vide e-tender No- KMSCL/ED/De-Addiction/RC/2024/008 DATED 29.05.2024
Essential Drugs Division
KMSCL-Re-tender for the procurement of Drugs for the year 2024-25- Technical Bid Evaluation- List of selected/rejected bidders/ products for price evaluation- Published- reg.
Essential Drugs Division
KMSCL- Re-tender for the procurement of Specialty Drugs for the year 2024-25- Technical Bid Evaluation- Defects noticed and status- Published- reg
Essential Drugs Division
Technical Bid Evaluation of Re-tender for the Procurement of Biolarvicide: Bacillus Thuringiensis var Israeliensis (BTI) Serotype.H-14 for Surveillance and Control of Communicable Disease Scheme & NVBDCP for the year 2023-24
Essential Drugs Division
Final Bid ranking status of E- Tender for the Procurement of Drugs for NVHCP for the year 2024-25 vide
Essential Drugs Division
Provisional Bid ranking status of e tender for the Procurement of Drugs for NVHCP for the year 2024-25
Essential Drugs Division
List of Selected bidders for Price Bid Opening of tender for the Procurement of Drugs for De-Addiction Centres for the year 2024-25
Essential Drugs Division
Re-tender for the procurement of drugs/supplies for the year 2024-25"vide Re-tender No. KMSCL/ED/III - VIII/RT/2024/016
Essential Drugs Division
KMSCL - E-tender for the Procurement of Drugs/ Supplies (Category III - VIII) for the year 2024-25 - Price Bid Evaluation - Items Deferred - Final Bid Status - Published
Essential Drugs Division
List of selected/ rejected bidders for Price bid evaluation against the tender for the Procurement of Drugs for NVHCP for the year 2024-25
Essential Drugs Division
KMSCL- Re- tender for the Procurement of Drugs for the year 2024-25- Technical Bid Evaluation - defects noticed/ status- Published- reg
Essential Drugs Division
KMSCL- Re- tender for the Procurement of Specialty Drugs for the year 2024-25- Technical Bid Evaluation - defects noticed and status- Published- reg
Essential Drugs Division
Notice on Technical Bid Evaluaiton of tender for the Procurement of Drugs for Anaemia Mukth Bharat for the year 2023-24
Essential Drugs Division
E- Tender for the Procurement of Drugs for De-Addiction Centers for the year 2024-25
Essential Drugs Division
KMSCL- E-tender for the Procurement of Veterinary Medicines for the year 2023-24- Price Bid Evaluation - Notice on Supplier wise rate quoted and Provisional Bid Ranking Status - Published- reg
Essential Drugs Division
Final Bid Ranking Status of e-tender for the Procurement of Anti Retroviral Drugs for KSACS for the year 2024-25
Essential Drugs Division
KMSCL-E- tender for the Procurement of Veterinary Medicines for the year 2023-24-Technical bid Evaluation- List of selected/rejected bidders products for price bid evaluation - Published -reg
Essential Drugs Division
E-tender for the Procurement of Recombinant Anti Haemophilic Factor VIII 1000 IU & 1500 IU for the year 2023-24- Price Bid Evaluation - Final Bid Status- Published - reg
Essential Drugs Division
KMSCL- E-tender for the procurement of Anti Cancer Drugs for the year 2024-25- Price Bid Evaluation - Items Deferred- Final Bid Status- Published - Reg
Essential Drugs Division
KMSCL- E-tender for the procurement of Drugs/Supplies (Category III-VIII) for the year 2024-25- Price Bid Evaluation - Final Bid Status- published- reg
Essential Drugs Division
KMSCL-E- Tender for the procurement of Anti Retroviral Drugs for KSACS for the year 2024-25 - Price bid evaluation - Provisional Bid Ranking Status- Published- reg
Essential Drugs Division
Final Bid ranking Status Published for the Procurement of Vitamin A Oral Solution IP for the year 2023-24
Essential Drugs Division
List of selected/ rejected bidders for Price bid evaluation for the Procurement of Anti Retroviral Drugs for KSACS for the year 2024-25
Essential Drugs Division
KMSCL- Re-tender for the Procurement of BIOLARVICIDE:BACILLUS THURINGIENSIS ISRAELIENSIS (BTI) For NVBDCP for the year 2023-24.
Essential Drugs Division
KMSCL- e- tender Document for the procurement of Veterinary Medicines for the year 2023-24 Technical Bid Evaluation - Defects noticed/ status - Published - reg
Essential Drugs Division
e-tender for the Procurement of Drugs/ Supplies (Category III - VIII) for the year 2024-25 - Supplier wise rate quoted and Provisional bid status - Publishing
Essential Drugs Division
KMSCL- E-Tender for the Procurement of Anti Retroviral Drugs for KSACS for the year 2024 - 25- Technical Bid Evaluation - Defects noticed/ status - Published
Essential Drugs Division
E-tender for the Procurement of Drugs/ Supplies for the year 2024-25 - Technical Bid Evaluation – List of selected/ rejected bidders/ products for price bid evaluation – Corrigendum published
Essential Drugs Division
E-tender for the Procurement of Drugs/ Supplies for the year 2024-25 - Technical Bid Evaluation – List of selected/ rejected bidders/ products for price bid evaluation – Published
Essential Drugs Division
E-tender for the Procurement of Drugs/ Supplies for the year 2024-25 - Technical Bid Evaluation – List of selected/ rejected bidders/ products for price bid evaluation – Published
Essential Drugs Division
Cancellation of tender -e-tender for the procurement of Biolarvicide: Bacillus Thuringiensis var Israeliensis (BTI) Serotype.H-14 -5% AS for NVBDCP for the year 2023-24
Essential Drugs Division
Notice on Provisional Bid ranking status of E- Tender for the Procurement of Vitamin A Oral Solution IP for the year 2023-24
Essential Drugs Division
E-tender for the Procurement of Anti Cancer Drugs for the year 2024-25 – Price Bid Evaluation – Final Bid Status– Published
Essential Drugs Division
e-tender for the Procurement of Drugs for De- Addiction Centers for the year 2024-25
Essential Drugs Division
e-tender for the procurement of drugs/supplies for the year 2024-25 - Technical bid evaluation -Defects noticed/status- Published
Essential Drugs Division
KMSCL- e- tender for the Procurement of Drugs for the year 2024- 25- Price Bid Evaluation - Items Deferred - Final Bid Status - Published- reg